This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Albany Molecular Research Inc (AMRI)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -3.28M 12.68M -3.78M 0.00
Operating Gains/Losses -1.12M 234.00K 176.00K 83.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -10.20M -9.33M -13.57M 2.73M
(Increase) Decrease in Inventories -7.97M -5.14M -2.21M 215.00K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -4.87M 7.70M 196.00K -11.95M
(Decrease) Increase In Other Current Liabilities -5.84M 3.59M 0.00 0.00
(Increase) Decrease In Other Working Capital 1.05M -2.60M 1.94M -5.34M
Other Non-Cash Items 11.39M 3.98M 10.42M -8.19M
Net Cash From Continuing Operations 1.91M 28.18M 15.34M -1.48M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.91M 28.18M 15.34M -1.48M
Sale of Property, Plant & Equipment 80.00K 300.00K 447.00K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -17.59M -11.55M -10.44M -11.26M
Acquisitions -145.75M 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 -817.00K
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -163.26M -11.25M -9.78M 3.97M
Issuance of Debt 35.00M 150.00M 5.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 2.31M 24.63M 531.00K 671.00K
Repayment of Long-Term Debt -5.06M -775.00K -2.84M -7.37M
Repurchase of Capital Stock -579.00K -164.00K 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 1.57M -36.80M -5.23M -270.00K
Net Cash From Financing Activities 33.24M 136.88M -2.53M -6.97M
Effect of Exchange Rate Changes -820.00K -1.18M 288.00K -1.28M
Net Change in Cash & Cash Equivalents -128.93M 152.63M 3.31M -5.76M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

AMRI Albany Molecular Research Inc

Chart of AMRI

Analysts Ratings for AMRI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

AMRI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs